ALLHAT was the largest antihypertensive treatment trial and the second largest lipid-lowering trial ever conducted. It also was a landmark cost-effectiveness study. The large size and diversity of participants, varied practice settings, and primary and secondary outcomes measured in ALLHAT makes the ALLHAT data set highly useful for epidemiologic investigations.